23:25:57 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2023-02-24 Bokslutskommuniké 2022
2022-11-29 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-05-06 Ordinarie utdelning BRIG 0.00 SEK
2022-05-04 Kvartalsrapport 2022-Q1
2022-02-28 Bokslutskommuniké 2021
2021-12-07 Extra Bolagsstämma 2021
2021-11-15 Kvartalsrapport 2021-Q3
2021-08-12 Kvartalsrapport 2021-Q2
2021-06-17 Årsstämma 2021
2021-05-18 Ordinarie utdelning BRIG 0.00 SEK
2021-05-12 Kvartalsrapport 2021-Q1
2021-02-26 Bokslutskommuniké 2020
2020-11-20 Extra Bolagsstämma 2020
2020-11-06 Kvartalsrapport 2020-Q3
2020-08-31 Kvartalsrapport 2020-Q2
2020-06-16 Ordinarie utdelning BRIG 0.00 SEK
2020-06-15 Årsstämma 2020
2020-04-30 Kvartalsrapport 2020-Q1
2020-02-27 Bokslutskommuniké 2019
2019-11-11 Extra Bolagsstämma 2019
2019-10-25 Kvartalsrapport 2019-Q3
2019-08-28 Kvartalsrapport 2019-Q2
2019-05-22 Kvartalsrapport 2019-Q1
2019-05-10 Ordinarie utdelning BRIG 0.00 SEK
2019-05-09 Årsstämma 2019
2019-02-27 Bokslutskommuniké 2018
2018-11-15 Kvartalsrapport 2018-Q3
2018-08-24 Kvartalsrapport 2018-Q2
2018-05-17 Ordinarie utdelning BRIG 0.00 SEK
2018-05-16 Årsstämma 2018
2018-04-20 Kvartalsrapport 2018-Q1
2018-03-23 Bokslutskommuniké 2017
2017-11-24 Kvartalsrapport 2017-Q3
2017-09-29 Extra Bolagsstämma 2017
2017-08-25 Kvartalsrapport 2017-Q2
2017-06-12 Ordinarie utdelning BRIG 0.00 SEK
2017-06-09 Årsstämma 2017
2017-05-19 Kvartalsrapport 2017-Q1
2017-02-24 Bokslutskommuniké 2016
2016-11-25 Kvartalsrapport 2016-Q3
2016-08-26 Kvartalsrapport 2016-Q2
2016-05-20 Kvartalsrapport 2016-Q1
2016-05-18 Ordinarie utdelning BRIG 0.00 SEK
2016-05-17 Årsstämma 2016
2016-04-22 Ordinarie utdelning BRIG 0.00 SEK
2016-03-31 Bokslutskommuniké 2015
2015-12-11 Kvartalsrapport 2015-Q3
2015-08-28 Kvartalsrapport 2015-Q2
2015-06-15 Ordinarie utdelning BRIG 0.00 SEK
2015-06-12 Årsstämma 2015
2015-06-05 Kvartalsrapport 2015-Q1
2015-03-31 Bokslutskommuniké 2014
2014-11-14 Kvartalsrapport 2014-Q3
2014-08-15 Kvartalsrapport 2014-Q2
2014-06-19 Ordinarie utdelning BRIG 0.00 SEK
2014-06-18 Årsstämma 2014
2014-05-09 Kvartalsrapport 2014-Q1
2014-02-06 Bokslutskommuniké 2013
2013-11-14 Kvartalsrapport 2013-Q3
2013-08-15 Kvartalsrapport 2013-Q2
2013-05-23 Ordinarie utdelning BRIG 0.00 SEK
2013-05-22 Årsstämma 2013
2013-05-08 Kvartalsrapport 2013-Q1
2013-02-20 Bokslutskommuniké 2012
2012-12-05 15-7 2012
2012-11-14 Kvartalsrapport 2012-Q3
2012-08-31 Kvartalsrapport 2012-Q2
2012-06-21 Ordinarie utdelning BRIG 0.00 SEK
2012-06-20 Årsstämma 2012
2012-05-08 Kvartalsrapport 2012-Q1
2012-02-29 Bokslutskommuniké 2011

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Brighter är verksamt inom hälsoteknik- och välfärdssektorn genom ett flertal olika bolag och varumärken. Koncernen kommersialiserar produkter och tjänster med fokus på data-driven behandling av diabetes på distans samt erbjuder ett flertal digitala och fysiska lösningar för stöd och omsorg i hemmet. Huvudkontoret ligger i Stockholm och bolaget fokuserar huvudsakligen på Sverige, USA, Mellanöstern och Sydostasien.
2021-06-21 20:15:00

The shareholders of Brighter AB (publ) reg. no 556736-8591, are hereby invited to attend the annual general meeting on Wednesday 21 July 2021 1:00 pm at Brighter's offices on Borgarfjordsgatan 18 in Kista.

THE RIGHT TO ATTEND AND THE REGISTRATION MADE TO THE COMPANY

Those wishing to attend the general meeting must

Firstly            be recorded in the share register maintained by Euroclear Sweden AB as of Tuesday 13 July 2021, and,

Secondly       notify the company of their intention to participate in the general meeting no later than Thursday 15 July 2021.

Notice of attendance shall be made in writing to Brighter AB (publ), Borgarfjordsgatan 18, 164 40 Kista or by email to ir@brighter.se.On giving notice of attendance, the shareholder should state the shareholder's name, personal identity number or equivalent /corporate identity number, address and telephone number as well as the number of proxy holders.

Nominee-Registered Shares

To participate in the annual general meeting, shareholders' whose shares are registered in the name of a nominee must request to have their shares owner-registered in the share register maintained by Euroclear Sweden AB at latest on Tuesday 13 July 2021. The request shall be made to the nominee and the registration may be made temporarily. Please note that the nominee decides on the routines for the requests, the requests shall therefore be submitted in due time and in accordance with the nominee's routines. The share register will be adjusted in accordance with voting registration if registration by the nominee has been submitted at the latest on Thursday 15 July 2021.

Proxies

A shareholder who is represented by a proxy must issue a dated and signed proxy for the proxy holder. If the proxy is issued by a legal person, a certificate of registration or equivalent must be submitted evidencing the signatory powers to represent the shareholder. To avoid crowding at the general meeting, the original signed proxy form and any certificate of registration should be sent to the company at the address above in good time of the annual general meeting. The proxy form is valid 5 years from the date of issue

The proxy form is available at the company's website www.brighter.se below "AGM 2021".

Precautions / Special Conditions due to Covid-19

The company has decided that no food or drinks will be served at the AGM as a precautionary measure due to covid-19. If you are registered for the AGM and have symptoms of respiratory illness, even mild, or if you have been in close contact with someone who is infected with the coronavirus, the company wishes you to refrain from attending. We would like to kindly remind you of the possibility of not attending in person and instead participate by proxy.

PROPOSAL FOR AGENDA

1. Election of chair of the general meeting
2. Preparation and approval of the voting lists
3. Election of one or two persons to approve the minutes
4. Approval of the agenda
5. Determination of whether the general meeting has been duly convened
6. Presentation of the annual report and the auditor's report and the consolidated financial statements and the consolidated auditor's report
7. Resolutions on:

a. adoption of the income statement and the balance sheet and the consolidated income statement and the consolidated balance sheet,
b. appropriation of the company's result according to the adopted balance sheet,
c. discharge from liability for the directors and the CEO

8. Resolution on the number of board directors
9. Resolution on the number of auditors
10. Resolution on the fees to the board of directors
11. Resolution on the fees to the auditor
12. Resolution on the board of directors and the chairman of the board
13. Resolution on the auditor
14. Resolution on nomination committee instruction
15. Resolution on issue authorisation
16. Resolution to call off LTI 2020 and withdraw the warrants
17. Resolution to call off the Board of Directors' Program and withdraw the warrants

PROPOSALS FOR RESOLUTIONS

Nomination Committee's proposal

Election of chair of the annual general meeting (item 1), Resolution on the number of board directors (item 8), Resolution on the number of auditors (item 9), Resolution on the fees to the board of directors (item 10), Resolution on the fees to the auditor (item 11), Resolution on the board of directors and the chairman of the board (item 12), Resolution on the auditor (item 13) and Resolution on nomination committee instruction (Item 14)

The Company's board cancelled the annual general meeting which, according to the sent out notice, was to be held on the 17 June 2021, instead the annual meeting will, in accordance to this notice, be held on the 21 of July 2021.The Company will, before the new date, await the nomination committee's proposal. Proposal from the nomination committee will be publicly announced in a press release and held available on the company's website under "AGM 2021".

The Board's Proposal

Appropriation of the company's result according to the adopted balance sheet (item 7 b)
The board proposes that no dividend shall be paid out and that the annual meeting shall have all available means totalling SEK 173,523,804, including 713,205,463 for the statutory reserve, accumulated loss SEK 320,978,901 and this year's loss on SEK 216,702,758, carried forward.

Resolution on Issue authorisation (item 15)

The board of directors propose that the annual general meeting resolves to authorise the board to, on one or more occasions until the next annual general meeting, with or without regard of shareholders' pre-emption rights, and within the limits set out in the articles of association regarding share capital, to resolve on issuance of shares, warrants and/or convertible bonds. The resolution may state that issuance of shares, warrants or convertibles shall be paid for with non-cash consideration, set-off issuance or in other ways subscribed in accordance with the conditions in chapter 13 section 5 first paragraph  6, chapter 15, section 5 first paragraph 6 or chapter 15, section 5 first paragraph 4 of the Swedish Companies Act.

Furthermore, the board propose that the CEO, or the one elected by the CEO, shall have the right to make minor adjustments in the provisions that may be demanded upon registration at the Companies Registration Office.

Resolution to call off LTI 2020 and withdraw the warrants (item 16)

Background

At the annual general meeting held on 15 June 2020 the shareholders resolved to adopt a performance-based incentive program "LTI 2020" for certain employees and contractors within the company and company group, see item 14 in last year's protocol from the annual general meeting on 15 June 2020, available at the company's website www.brighter.se.

At the same annual meeting there was a proposal for resolution on delivery and cost-hedging measures for LTI 2020, "Cost-hedging Measures for LTI 2020", see item 15 in the protocol

in last year's protocol from the annual general meeting on 15 June 2020, available at the company's website www.brighter.se, and and issuance of warrants "Warrants LTI 2020".

The board has not implemented the annual meeting's decision on LTI 2020. The incentive program has not been carried out. The board is of the opinion that the program is no longer relevant for a company after a year with big changes, not least professionally. The board therefore proposes that the program and warrants shall be cancelled. The board is currently evaluating the possibility and way of a new incentive program and may give a new proposal to the shareholders during the year.

Proposal

In the light of what has been mentioned above, the board proposes to not carry out the incentive program that was decided upon on earlier meetings, instead the program shall be cancelled, and that the company does not carry out the Warrants LTI 2020 that has been allotted under Cost-hedging Measures for LTI 2020.

Resolution to call off the Board of Directors' Program and withdraw the warrants ( item 17)

Background

At the annual general meeting held on 15 June 2020 the shareholders resolved to adopt a  incentive program "Director's Program" for board directors within the company, see item 16 in last year's protocol from the annual general meeting on 15 June 2020, available at the company's website www.brighter.se.

At the same annual meeting there was a proposal for resolution on delivery and cost-hedging measures for LTI 2020, "cost-hedging measures for the Directors' Program", see item 17 in the protocol in last year's protocol from the annual general meeting on 15 June 2020, available at the company's website www.brighter.se, and issuance of warrants for directors "Warrants for Directors".

The board has not implemented the Director's Program and so no issuance has been carried out. The board is of the opinion that the program is no longer relevant for a company after a year with big changes, not least professionally. The board therefore proposes that the program and the warrants shall be cancelled.

Proposal

In the light of what has been mentioned above, the board proposes to not carry out the Director's Program that was decided upon on earlier meetings, instead the program shall be cancelled, and that the company does not carry out the Warrants for Directors  that has already been allotted under Cost-hedging Measures for the Director's Program.

DOCUMENTS

Accounting documents and audit report for 2020 will be available at the company and at the company's website, www.brighter.se, below "AGM 2021" and shall immediately be sent without cost for the receiver, to shareholders that so requests and states their postal addresses. If there are other decision documents, it will be held available in the same way at the latest three weeks before the annual general meeting. Such request shall be made in writing to the address Brighter AB (publ), Borgarfjordsgatan 18, 164 40, Kista or by email to ir@brighter.se.

SHAREHOLDERS' RIGHT TO REQUEST INFORMATION

Upon request by any shareholder and where the board of directors believes that such may take place without significant harm to the company, the board of directors and CEO shall provide information at the general meeting in respect to any circumstances which may affect the assessment of a matter on the agenda, any circumstances which may affect the assessment of the company's or the company's subsidiaries' financial position, consolidated financial statements and the company's relationship to another group company.

PROCESSING OF PERSONAL DATA

For information on how your personal data is processed, please see https://www.euroclear.com/dam/ESw/Legal/Privacy_Notice_Boss_Final_SWE_30112020.pdf  

____________

Stockholm in June 2021

Brighter AB (publ)

The Board of Directors

For further information, please contact:

Investor Relations

IR@brighter.se

Certified Adviser

Brighter's Certified Adviser is Eminova Fondkommission AB, +46 (0)8 - 684 211 10, adviser@eminova.se,www.eminova.se.

About Brighter AB (publ)

Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers - aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.